BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 10900099)

  • 1. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H; McCormick SA; Finger PT
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
    Kurli M; Finger PT
    Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
    Finger PT; Czechonska G; Liarikos S
    Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
    Werschnik C; Lommatzsch PK
    Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy.
    Salomão DR; Mathers WD; Sutphin JE; Cuevas K; Folberg R
    Ophthalmology; 1999 Sep; 106(9):1756-60; discussion 1761. PubMed ID: 10485547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
    Finger PT; Sedeek RW; Chin KJ
    Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conjunctival primary acquired melanosis].
    Krohn J; Monge OR
    Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2480-2. PubMed ID: 16186865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
    Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO
    Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment.
    Chalasani R; Giblin M; Conway RM
    Clin Exp Ophthalmol; 2006; 34(7):708-14. PubMed ID: 16970772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years].
    Schmidt M; Maier M; Schmidt T; Klaehsen D; Merté RL
    Klin Monbl Augenheilkd; 2001 Dec; 218(12):805-9. PubMed ID: 11805873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
    Ditta LC; Shildkrot Y; Wilson MW
    Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C.
    Pe'er J; Frucht-Pery J
    Am J Ophthalmol; 2005 Feb; 139(2):229-34. PubMed ID: 15733981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia.
    Frucht-Pery J; Pe'er J
    Arch Ophthalmol; 1996 Oct; 114(10):1261-4. PubMed ID: 8859090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical mitomycin treatment for primary acquired melanosis of the conjunctiva.
    Yuen VH; Jordan DR; Brownstein S; Dorey MW
    Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):149-51. PubMed ID: 12644763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman.
    Colby KA; Nagel DS
    Cornea; 2005 Apr; 24(3):352-5. PubMed ID: 15778614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a short-term topical interferon α-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia.
    Garip A; Schaumberger MM; Wolf A; Herold TR; Miller CV; Klingenstein A; Schebitz-Walter K; Hintschich CR
    Orbit; 2016; 35(1):29-34. PubMed ID: 26636727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival melanoma arising from primary acquired melanosis in a patient with neurofibromatosis type I.
    Stacy RC; Kenyon KR; Jakobiec FA; Colby KA
    Cornea; 2010 Feb; 29(2):232-4. PubMed ID: 20023582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
    Akpek EK; Ertoy D; Kalayci D; Hasiripi H
    Cornea; 1999 Jan; 18(1):59-62. PubMed ID: 9894938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma.
    Sacu S; Ségur-Eltz N; Horvat R; Lukas JR; Zehetmayer M
    Am J Ophthalmol; 2003 Aug; 136(2):375-7. PubMed ID: 12888073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
    Lichtinger A; Pe'er J; Frucht-Pery J; Solomon A
    Ophthalmology; 2010 Mar; 117(3):431-7. PubMed ID: 20060167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.